Mumps: A case report

Abstract

The widespread of mumps and its medical and social significance determine the relevance of further study of the etiology, epidemiology, diagnosis, treatment, and prevention of mumps infection. Despite the lack of mortality, the possible occurrence of complications that affect the suppression of male reproductive function makes mumps a priority. Official statistics show the annual incidence of mumps in the Russian Federation, estimated in hundreds of cases up to several thousand (2017–2018). The continued spread of mumps is associated with violations of immunization regimens, underestimation of the unvaccinated population or unreliability of the reported data, introduction of new viral genotypes capable of bypassing vaccine immunity, and natural weakening of post-vaccination immunity.

The presented clinical case refers to an outpatient case of mumps in a 53-year-old man with a delayed diagnosis despite the typical clinical manifestations. The clinical case demonstrates the lack of awareness of outpatient practitioners about the manifestations of mumps. The causes of mumps in older age groups and possible ways to solve the problem are discussed.

Keywords

mumps / immunoprophylaxis of mumps infection / сase report

References

[1] Yuminova NV, Mardanly SG, Kiseleva VA, Kontarov NA, Pomazanov VV. Mumps epidemic (virus, clinic, pathogenesis, diagnosis, epidemiology, vaccination), the effectiveness of the national program to reduce morbidity in the Russian Federation. Textbook. Orekhovo-Zuyevo: GGTU; 2023. 78 p. (In Russ.) EDN: LSVMVM

[2] Юминова Н.В., Марданлы С.Г., Киселева В.А., Контаров Н.А., Помазанов В.В. Эпидемический паротит (вирус, клиника, патогенез, диагностика, эпидемиология, вакцинопрофилактика), эффективность выполнения национальной программы по снижению заболеваемости в Российской Федерации: учебное пособие. Орехово-Зуево: ГГТУ, 2023. 78 с. EDN: LSVMVM

[3] The number of reported cases of infectious diseases. In: Unified Interdepartmental Information and Statistical System (EMISS) [Internet]. Available from: https://www.fedstat.ru/indicator/38208 (In Russ.)

[4] Число зарегистрированных случаев инфекционных заболеваний. В: Единая межведомственная информационно-статистическая система (ЕМИСС) [интернет]. Режим доступа: https://www.fedstat.ru/indicator/38208

[5] Habib MA, Povey M, Casabona G, Singh T, Abu-Elyazeed R. Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines. Hum Vaccin Immunother. 2023;19(1):2188852. doi: 10.1080/21645515.2023.2188852

[6] Habib M.A., Povey M., Casabona G., Singh T., Abu-Elyazeed R. Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines // Hum Vaccin Immunother. 2023. Vol. 19, N 1. P. 2188852. doi: 10.1080/21645515.2023.2188852

[7] Namazova-Baranova LS, Fedoseenko MV, Grinchik PR, et al. Immunization and Immunization Coverage According to National Immunization Schedule for Children Population: Cross-Sectional Multi-Centre Study. Pediatric pharmacology. 2021;18(2):110–117. (In Russ.) doi: 10.15690/pf.v18i2.2218

[8] Намазова-Баранова Л.С., Федосеенко М.В., Гринчик П.Р., и др. Привитость и охват иммунизацией в соответствии с национальным календарем профилактических прививок детского населения: одномоментное многоцентровое исследование // Педиатрическая фармакология. 2021. Т. 18, № 2. С. 110–117. doi: 10.15690/pf.v18i2.2218

[9] Grinchik PR, Namazova-Baranova LS, Fedoseenko MV, et al. Comparative Analysis of Immunization and Immunization Coverage in Children of Russian Federation Federal Districts. Pediatric pharmacology. 2022;19(1):6–19. (In Russ.) doi: 10.15690/pf.v18i6.2351

[10] Гринчик П.Р., Намазова-Баранова Л.С., Федосеенко М.В., и др. Сравнительный анализ показателей привитости и охвата иммунизацией детского населения на территории федеральных округов Российской Федерации // Педиатрическая фармакология. 2022;19(1):6–19. doi: 10.15690/pf.v18i6.2351

[11] Tikhomirova КК, Konstantinova YuЕ, Kharit SМ. Measles, rubella, mumps — problem that occurred again. Poliklinika. 2020;(4):39–45. (In Russ.) EDN: DVCYLS

[12] Тихомирова К.К., Константинова Ю.Е., Харит С.М. Корь, краснуха, паротит — старая новая проблема // Поликлиника. 2020. № 4. С. 39–45. EDN: DVCYLS

[13] Turaeva NV, Frolov RA, Tsvirkun OV, Gerasimova AG. Characteristics of the epidemiological situation of mumps in the world at the present stage. Epidemiology and Vaccinal Prevention. 2021;20(2):74–82. (In Russ.) doi: 10.31631/2073-3046-2021-20-2-74-82

[14] Тураева Н.В., Фролов Р.А., Цвиркун О.В., Герасимова А.Г. Характеристика эпидемиологической ситуации по эпидемическому паротиту в мире на современном этапе // Эпидемиология и Вакцинопрофилактика. 2021. Т. 20, № 2. С. 74–82. doi: 10.31631/2073-3046-2021-20-2-74-82

[15] Gokhale DV, Brett TS, He B, King AA, Rohani P. Disentangling the causes of mumps reemergence in the United States. Proc Natl Acad Sci U S A. 2023;120(3):e2207595120. doi: 10.1073/pnas.2207595120

[16] Gokhale D.V., Brett T.S., He B., King A.A., Rohani P. Disentangling the causes of mumps reemergence in the United States // Proc Natl Acad Sci U S A. 2023. Vol. 120, N 3. P. e2207595120. doi: 10.1073/pnas.2207595120

[17] Hiebert J, Saboui M, Frost JR, et al. Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002–2020. Vaccine. 2023;41(25):3728–3739. doi: 10.1016/j.vaccine.2023.04.078

[18] Hiebert J., Saboui M., Frost J.R., et al. Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002–2020 // Vaccine. 2023. Vol. 41, N 25. P. 3728–3739. doi: 10.1016/j.vaccine.2023.04.078

[19] Chekhlyaeva TS, Erokhov DV, Andrievskaya IYu, Zherdeva PE, Tikhonova NT. Genetic diversity of the mumps viruses (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus): an overview. Problems of Virology. 2022;67(2):95–106. (In Russ.) doi: 10.36233/0507-4088-98

[20] Чехляева Т.С., Ерохов Д.В., Андриевская И.Ю., Жердева П.Е., Тихонова Н.Т. Обзор генетического разнообразия вируса эпидемического паротита (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus) // Вопросы вирусологии. 2022. Т. 67, № 2. С. 95–106. doi: 10.36233/0507-4088-98

[21] Semerikov VV, Yuminova NV, Postanogova NO, Sofronova LV. Mumps: achievements, problems and ways of solution. Pharmacy & Pharmacology. 2020;8(5):296–303. (In Russ.) doi: 10.19163/2307-9266-2020-8-5-296-303

[22] Семериков В.В., Юминова Н.В., Постаногова Н.О., Софронова Л.В. Эпидемический паротит: достижения, проблемы и пути решения // Фармация и фармакология. 2020. Т. 8, № 5. С. 296–303. doi: 10.19163/2307-9266-2020-8-5-296-303

[23] Sun J, Li M, Zhang L, et al. Mumps-specific antibody persistence in children aged 3-7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China. Hum Vaccin Immunother. 2023;19(1):2166758. doi: 10.1080/21645515.2023.2166758

[24] Sun J., Li M., Zhang L., et al. Mumps-specific antibody persistence in children aged 3-7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China // Hum Vaccin Immunother. 2023. Vol. 19, N 1. P. 2166758. doi: 10.1080/21645515.2023.2166758

[25] Cataldi JR, O’Leary ST, Marlow MA, et al. Pediatricians’ Knowledge and Practices Related to Mumps Diagnosis and Prevention. J Pediatr. 2021;239:81–88.e2. doi: 10.1016/j.jpeds.2021.08.036

[26] Cataldi J.R., O’Leary S.T., Marlow M.A., et al. Pediatricians’ Knowledge and Practices Related to Mumps Diagnosis and Prevention // J Pediatr. 2021. Vol. 239. P. 81–88.e2. doi: 10.1016/j.jpeds.2021.08.036

[27] Semerikov VV, Sofronova LV, Postanogova NO, et al. Standard definition of a clinical case of mumps and diagnostic effectiveness of the test systems used in the modern period. Journal of microbiology, epidemiology and immunobiology. 2023;100(1):65–73. (In Russ.) doi: 10.36233/0372-9311-340

[28] Семериков В.В., Софронова Л.В., Постаногова Н.О., и др. Стандартное определение клинического случая эпидемического паротита и диагностическая эффективность применяемых тест-систем в современный период // Журнал микробиологии, эпидемиологии и иммунобиологии. 2023. Т. 100, № 1. С. 65–73. doi: 10.36233/0372-9311-340

[29] Gontarev SN, Gontareva IS, Mozhaitina YI, et al. Clinical features of salivary gland disease in viral infections (literature review). Journal of new medical technologies. 2023;30(3):43–47. (In Russ.) doi: 10.24412/1609-2163-2023-3-43-47

[30] Гонтарев С.Н., Гонтарева И.С., Можаитина Ю.И., и др. Клинические особенности заболевания слюнных желёз при вирусных инфекциях (обзор литературы) // Вестник новых медицинских технологий. 2023. Т. 30, № 3. С. 43–47. doi: 10.24412/1609-2163-2023-3-43-47

RIGHTS & PERMISSIONS

Eco-vector